| 2165 |
1756: Decreased, 11KT |
330: Decrease, Fertility |
Jul 21, 2020 |
Jul 21, 2020 |
None
|
| 2166 |
1756: Decreased, 11KT |
1798: Decreased spermatogenesis |
Jul 21, 2020 |
Jul 21, 2020 |
1 AOP
|
| 3518 |
2320: Decreased, 17βHSD3 activity |
1690: Decrease, circulating testosterone levels |
Apr 8, 2025 |
Apr 8, 2025 |
None
|
| 9 |
8: Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity |
179: Decrease, Fatty acid β-oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1530 |
1401: Decreased, 5-HT3 |
1344: Increased, seizure |
Jun 1, 2017 |
Jun 1, 2017 |
1 AOP
|
| 2401 |
1880: Decreased, ALDH1A activity |
1881: Decreased, atRA concentration |
May 24, 2021 |
Dec 18, 2024 |
2 AOPs
|
| 2477 |
1881: Decreased, atRA concentration |
1882: Disrupted, meiotic initiation in oocyte |
Sep 10, 2021 |
Jul 4, 2025 |
1 AOP
|
| 2561 |
1881: Decreased, atRA concentration |
1682: Disruption, Progenitor cells of second heart field |
Feb 8, 2022 |
Feb 15, 2022 |
1 AOP
|
| 2630 |
1987: Decreased , Androgen and Progestin |
1988: Decreased, Maturation Inducing Steroids Surge by Granulosa cells |
Apr 5, 2022 |
Apr 5, 2022 |
1 AOP
|
| 1542 |
1409: Decreased, angiogenesis |
1385: Activated, gastric ulcer formation |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 645 |
627: Decreased, anxiety |
629: Decreased, sheltering |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1248 |
1183: Decreased, Apoptosis (Epithelial Cells) |
1192: Increased, Ductal Hyperplasia |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2914 |
1183: Decreased, Apoptosis (Epithelial Cells) |
854: Alterations, Cellular proliferation / hyperplasia |
May 11, 2023 |
May 11, 2023 |
1 AOP
|
| 801 |
800: Decreased, Aromatase (Cyp19a1) mRNA |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 2870 |
2123: decreased, Bcl-2 |
55: Cell injury/death |
Apr 4, 2023 |
Apr 4, 2023 |
1 AOP
|
| 2873 |
2123: decreased, Bcl-2 |
1825: Increase, Cell death |
Apr 4, 2023 |
Apr 4, 2023 |
None
|
| 1540 |
1407: Decreased, bicarbonate |
1405: Reduced, mucosal defense |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 1101 |
1058: Decreased, bile flow |
1059: Increased, cholestasis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3347 |
2261: Decreased, blood plasma volume |
2238: Increased, Blood viscosity |
Sep 20, 2024 |
Dec 3, 2024 |
1 AOP
|
| 62 |
52: Decreased, Calcium influx |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 347 |
52: Decreased, Calcium influx |
381: BDNF, Reduced |
Nov 29, 2016 |
Jun 13, 2018 |
2 AOPs
|
| 3167 |
656: Decreased COUP-TFII in Leydig cells |
647: Decreased, steroidogenic protein expression |
Mar 20, 2024 |
Dec 3, 2024 |
2 AOPs
|
| 2072 |
807: Decreased, cholesterol |
1756: Decreased, 11KT |
Mar 23, 2020 |
May 6, 2020 |
1 AOP
|
| 3201 |
807: Decreased, cholesterol |
1690: Decrease, circulating testosterone levels |
Apr 25, 2024 |
Apr 25, 2024 |
1 AOP
|
| 3519 |
2321: Decreased, CYP11A1 activity |
2319: Decreased, Pregnenolone levels |
Apr 8, 2025 |
Apr 8, 2025 |
None
|